Monoclonal Antibodies Lead the Biosimilars Market: Segment Analysis

bir ses eklendi Art

2026-10-05 14:26:42 -

Biosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives to...

0 Yorumlar 0 hisse senetleri 38 Views 0 önizleme